Lb Pharmaceuticals Balance Sheet (2024-2026) | LBRX

Balance Sheet Sep2024 Dec2024 Mar2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter) 0.10M0.34M0.42M0.50M
Assets
Current Assets
Cash & Equivalents (Quarter) 22.98M269.74M250.17M320.68M
Prepaid Assets (Quarter) 0.27M1.92M13.22M1.38M
Current Assets (Quarter) 28.88M316.40M308.43M389.07M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 1.86M1.64M1.58M1.53M
Other Non-Current Assets (Quarter) 0.50M0.51M0.77M0.78M
Non-Current Assets (Quarter) 4.66M4.34M4.50M4.41M
Assets (Quarter) 33.53M320.75M312.93M393.48M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 2.32M2.59M2.13M7.12M
Payables (Quarter) 2.32M2.59M2.13M7.12M
Accumulated Expenses (Quarter) 0.80M1.13M0.52M0.26M
Other Accumulated Expenses (Quarter) 0.23M0.20M0.27M0.13M
Short term Debt (Quarter) 2.50M0.94M1.34M1.14M
Current Leases (Quarter) 0.49M0.73M0.73M0.73M
Total Current Liabilities (Quarter) 8.11M6.65M7.44M10.91M
Non-Current Liabilities
Operating Leases (Quarter) 3.22M2.94M2.84M2.74M
Other Non-Current Liabilities (Quarter) 2.50M0.94M1.34M1.14M
Total Non-Current Liabilities (Quarter) 11.32M9.58M10.28M13.65M
Total Liabilities (Quarter) 91.45M13.83M99.34M10.53M11.62M14.79M
Shareholder's Equity
Total Debt (Quarter) 2.50M0.94M1.34M1.14M
Common Equity (Quarter) -91.45M-94.55M-99.34M310.22M301.31M378.69M
Shareholder's Equity (Quarter) -91.45M-94.55M-99.34M310.22M301.31M378.69M
Liabilities and Shareholders Equity (Quarter) 33.53M320.75M312.93M393.48M
Retained Earnings (Quarter) -104.32M-0.05M-129.53M0.21M
Preferred Shares (Quarter) 107.06M
Treasury Shares (Quarter) 0.01M6.65M0.09M
Shares Outstanding (Quarter) 0.25M0.25M0.25M3.19M25.30M28.67M